Eventide Asset Management’s Eli Lilly LLY Stock Holding History

Eventide Asset Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.62M	Buy	5,121 +425	+9%	+$431K	0.08%	166
2025 Q4	$5.06M	Sell	4,696 -244	-5%	-$233K	0.08%	168
2025 Q3	$3.68M	Buy	4,940 +648	+15%	+$482K	0.06%	149
2025 Q2	$3.34M	Sell	4,292 -480	-10%	-$373K	0.06%	149
2025 Q1	$3.94M	Buy	4,772 +574	+14%	+$478K	0.08%	148
2024 Q4	$3.24M	Buy	4,198 +70	+2%	+$58K	0.06%	159
2024 Q3	$3.66M	Buy	4,128 +2,946	+249%	+$2.65M	0.06%	145
2024 Q2	$1.07M	Buy	1,182 +308	+35%	+$246K	0.02%	160
2024 Q1	$680K	Buy	+874	New	+$622K	0.01%	157

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Eventide Asset Management's LLY Position: Q1 2026 in Review

Eventide Asset Management increased its Eli Lilly (LLY) stake by 9.1% in Q1 2026, buying an estimated $431K and bringing the position to 5,121 shares worth $4.62M. The position accounts for 0.08% of the portfolio, ranked #166.

Eventide Asset Management first reported a position in LLY in Q1 2024 and has held it in 9 quarters since. The position peaked at $5.06M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Eventide Asset Management held 5,121 shares of Eli Lilly worth $4.62M as of Q1 2026.
Eventide Asset Management bought 425 Eli Lilly shares in Q1 2026, an estimated $431K.
Eli Lilly made up 0.08% of Eventide Asset Management's portfolio in Q1 2026, its #166 holding.
Eventide Asset Management first reported a position in Eli Lilly in Q1 2024 and has held it in 9 quarters since.
Eventide Asset Management's Eli Lilly position peaked at $5.06M in Q4 2025.
4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Eventide Asset Management's 13F filing for Q1 2026, filed 15 May 2026.